º£½ÇÊÓÆµ

Oops.

Our website is temporarily unavailable in your location.

We are working hard to get it back online.

PRIVACY
Retail & Consumer

Covid jab services boosts sales at Boots' US owner

Boots pharmacy sales have also been helped by demand for Covid-19 travel testing

Boots the chemist

Boots owner Walgreens Boots Alliance (WBA) said it did better in the three months to November than it had expected, helped by offering Covid-19 jabs.

The US pharmacy group said it was significantly boosted by vaccinations and testing across sites as well as higher flu vaccinations.

The group – which owns Nottingham headquartered Boots – reported that first quarter sales increased 7.8 per cent to $33.9 billion (£25 billion).

Its international retail pharmacy operation, including Boots, saw a 35.8 per cent rise in quarterly sales to $5.8 billion (£4.3 billion).

It also highlighted 16.3 per cent like-for-like retail sales growth across its Boots º£½ÇÊÓÆµ business, as it was boosted by the easing of pandemic restrictions.

The company said it benefited from a 12 per cent increase in the size of customers’ baskets, while online sales also continued to grow.

Boots like-for-like pharmacy sales rose 8.8 per cent as they were boosted by stronger demand for services such as Covid-19 travel testing.

Sebastian James, managing director at Boots º£½ÇÊÓÆµ, said: “Boots delivered another strong performance this quarter with both retail and pharmacy sales continuing to increase year on year, along with very encouraging market share growth.